BIOMARIN PHARMACEUTICAL INC (BMRN) /
The revenue of BIOMARIN PHARMACEUTICAL INC over the past 10 years
Chart BIOMARIN PHARMACEUTICAL INC: revenue, fiscal 2016–2025 Open the chart →BIOMARIN PHARMACEUTICAL INC reported revenue of $3.22B in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $1.12B — up 188% over 9 years. Year over year, revenue rose 8 times and fell once. The largest one-year move was in fiscal 2024: up 18%, from $2.42B to $2.85B.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $3.22B |
| 2024ended Dec 31, 2024 | $2.85B |
| 2023ended Dec 31, 2023 | $2.42B |
| 2022ended Dec 31, 2022 | $2.1B |
| 2021ended Dec 31, 2021 | $1.85B |
| 2020ended Dec 31, 2020 | $1.86B |
| 2019ended Dec 31, 2019 | $1.7B |
| 2018ended Dec 31, 2018 | $1.49B |
| 2017ended Dec 31, 2017 | $1.31B |
| 2016ended Dec 31, 2016 | $1.12B |
Fiscal years as BIOMARIN PHARMACEUTICAL INC reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on BIOMARIN PHARMACEUTICAL INC
- The profitability of BIOMARIN PHARMACEUTICAL INC
- The cash flow of BIOMARIN PHARMACEUTICAL INC
- The debt of BIOMARIN PHARMACEUTICAL INC
- All of BIOMARIN PHARMACEUTICAL INC's financials, charted
Companies of a similar size
Not investment advice. This page shows what BIOMARIN PHARMACEUTICAL INC filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.